BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16824361)

  • 1. [Superiority, equivalence and not inferiority studies for clinical trials].
    Attanasio E
    Prof Inferm; 2006; 59(1):49-57. PubMed ID: 16824361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The importance of equivalence trials in showing the usefulness of treatments].
    Hermens ML; van Hout HP; Terluin B; Adèr HJ; de Haan M
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2162-6. PubMed ID: 14626832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodology of superiority vs. equivalence trials and non-inferiority trials.
    Christensen E
    J Hepatol; 2007 May; 46(5):947-54. PubMed ID: 17412447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statistical notes. From superiority to non-inferiority clinical trials: a leap in the dark?].
    Marubini E; Rebora P; Reina G
    Ital Heart J Suppl; 2004 Sep; 5(9):712-9. PubMed ID: 15568609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods in equivalence and non-inferiority trials].
    Christensen E
    Ugeskr Laeger; 2008 Sep; 170(38):2977-9. PubMed ID: 18808753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority.
    Goeman JJ; Solari A; Stijnen T
    Stat Med; 2010 Sep; 29(20):2117-25. PubMed ID: 20658478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Equivalence studies in cardiovascular diseases].
    Barbieri P; Marubini E
    Ital Heart J Suppl; 2004 Apr; 5(4):267-75. PubMed ID: 15346693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active-control trials with binary data: a comparison of methods for testing superiority or non-inferiority using the odds ratio.
    Siqueira AL; Whitehead A; Todd S
    Stat Med; 2008 Feb; 27(3):353-70. PubMed ID: 17628041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size estimation for non-inferiority trials of time-to-event data.
    Crisp A; Curtis P
    Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C
    Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical considerations for confirmatory clinical trials for similar biotherapeutic products.
    Njue C
    Biologicals; 2011 Sep; 39(5):266-9. PubMed ID: 21807534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing non-inferiority: a combination approach.
    Gao P; Ware JH
    Stat Med; 2008 Feb; 27(3):392-406. PubMed ID: 17575568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of equivalence in cardiovascular diseases].
    Barbieri P; Marubini E
    Ital Heart J Suppl; 2004 Apr; 5(4):267-75. PubMed ID: 15185464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of intent-to-treat and per-protocol results in antibiotic non-inferiority trials.
    Brittain E; Lin D
    Stat Med; 2005 Jan; 24(1):1-10. PubMed ID: 15532089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ['Non-inferiority' trials. Tips for the critical reader. Research methodology 3].
    Soonawala D; Dekkers OM
    Ned Tijdschr Geneeskd; 2012; 156(19):A4665. PubMed ID: 22571548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar, the same or just not different: a guide for deciding whether treatments are clinically equivalent. [Dept. of Medicine, Division of Cardiology, Univ. of Western Ontario, London, Ontario].
    Massel D
    Can J Cardiol; 1999 May; 15(5):556-62. PubMed ID: 10350665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superiority inferences on individual endpoints following noninferiority testing in clinical trials.
    Logan BR; Tamhane AC
    Biom J; 2008 Oct; 50(5):693-703. PubMed ID: 18932132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.